Hospital
Southern Illinois Hospital Services
Southern Illinois Hospital Services was paid $1.68M by Medicaid between Jan 2018 and May 2022, across 81 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 63% of everything it billed.
33Billing provider infoSOUTHERN ILLINOIS HOSPITAL SERVICES
CARBONDALE, IL 62901
CARBONDALE, IL 62901
33aNPI1093801797assigned 10/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.68M
24GClaims54,343
24DCodes billed81
24AFirst – last monthJan 2018 – May 2022
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#35 of 129
Median peer was paid$547K
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,467 | $432K | |
| 2019 | 25,158 | $735K | |
| 2020 | 11,636 | $357K | |
| 2021 | 1,298 | $96K | |
| 2022 | 784 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 63% | 11,732 | 2,392 | $1.06M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 2,587 | 2,247 | $201K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5.7% | 1,617 | 1,539 | $97K |
| 97161 | 4.6% | 762 | 639 | $78K | |
| 97162 | 3.2% | 480 | 428 | $53K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 2.6% | 1,204 | 1,150 | $43K |
| 80053 | Comprehensive metabolic panel | 1.4% | 5,262 | 3,840 | $23K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 1,557 | 277 | $18K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 92 | 53 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,562 | 4,850 | $10K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 322 | 290 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 654 | 229 | $8K |
69 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,513 | $7K |
| 72110 | <1% | 396 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 642 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 753 | $6K |
| 97010 | <1% | 230 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 688 | $3K |
| 77066 | Tomosynthesis, mammo | <1% | 42 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 897 | $3K |
| 82607 | <1% | 727 | $2K | |
| 72050 | <1% | 154 | $2K | |
| 72100 | <1% | 166 | $2K | |
| 82728 | <1% | 977 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 379 | $1K |
| 83550 | <1% | 598 | $1K | |
| 85610 | <1% | 924 | $1K | |
| 83735 | <1% | 553 | $1K | |
| 82746 | <1% | 411 | $984.77 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 45 | $982.37 |
| 80061 | Lipid panel | <1% | 777 | $941.66 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 99 | $936.40 |
| 88108 | <1% | 241 | $923.85 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 619 | $916.08 |
| 84439 | <1% | 554 | $883.78 | |
| 92558 | <1% | 75 | $852.09 | |
| 83540 | <1% | 623 | $838.62 | |
| 86038 | <1% | 111 | $830.01 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 72 | $792.36 |
| 83615 | <1% | 318 | $749.70 | |
| 81003 | <1% | 1,257 | $732.90 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 55 | $731.53 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $667.03 |
| 72040 | <1% | 57 | $588.16 | |
| 86901 | <1% | 594 | $585.44 | |
| 86850 | <1% | 529 | $579.50 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 254 | $578.80 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $524.40 |
| 87581 | <1% | 92 | $512.46 | |
| 87486 | <1% | 92 | $512.46 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 98 | $494.28 |
| 86900 | <1% | 551 | $357.67 | |
| 85045 | <1% | 373 | $309.87 | |
| 84165 | <1% | 44 | $255.50 | |
| 85730 | <1% | 202 | $246.01 | |
| 97166 | <1% | 24 | $166.93 | |
| 85651 | <1% | 189 | $159.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 853 | $143.96 |
| 73562 | <1% | 16 | $137.62 | |
| 83516 | <1% | 49 | $98.21 | |
| 87186 | <1% | 16 | $82.50 | |
| 86140 | <1% | 95 | $70.99 | |
| 84160 | <1% | 43 | $58.65 | |
| 81025 | <1% | 53 | $51.53 | |
| 86592 | <1% | 73 | $46.84 | |
| 84100 | <1% | 30 | $45.32 | |
| 84702 | <1% | 14 | $43.12 | |
| 87340 | <1% | 17 | $39.60 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 740 | $19.42 |
| 84425 | <1% | 15 | $18.72 | |
| 82247 | <1% | 15 | $18.14 | |
| 82043 | <1% | 15 | $17.33 | |
| 84075 | <1% | 12 | $12.20 | |
| 84450 | <1% | 12 | $12.20 | |
| 84155 | <1% | 12 | $8.75 | |
| 36591 | 0% | 414 | $0.00 | |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 15 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 146 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 290 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 198 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 345 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARTKE, SHANNON (CORPORATE DIRECTOR, PATIENT FINANCI)
| Provider | Location | Paid |
|---|---|---|
| Southern Illinois Hospital Services | Herrin, IL | $5.45M |
| Southern Illinois Hospital Services | Murphysboro, IL | $1.00M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.